16 Results

People

  1. Kris
    Kris
  2. Kelly
    Kelly
  3. Pfister
    Pfister
  4. Rigas
    Rigas
  5. Warrell
    Warrell
  6. Antonescu
    Antonescu
  7. Balagula
    Balagula
  8. Basch
    Basch
  9. Berman
    Berman
  10. Boyle
    Boyle

Groups

  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (6)
  3. Center for Hematologic Malignancies (4)
  4. Dermatology Service (4)
  5. Dermatology (4)
  6. Division of Subspecialty Medicine (4)
  7. Hematologic Malignancies, Division of (3)
  8. Surgery (3)
  9. Survivorship Research (3)
  10. Thoracic Oncology (3)
  1. "cheilitis"
Formats
  1. Journal Article (15)
  2. Research Letter (1)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (6)
  3. Center for Hematologic Malignancies (4)
  4. Dermatology (4)
  5. Dermatology Service (4)
  6. Division of Subspecialty Medicine (4)

More Groups

People
  1. Mark Kris (3)
  2. David Pfister (2)
  3. James Rigas (2)
  4. Mario Lacouture (2)
  5. Raymond Warrell (2)
  6. William Kelly (2)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2020 (1)
  4. 2014 (1)
  5. 2013 (1)
  6. 2010 (2)

More Years

Publications
  1. Cancer (2)
  2. Clinical Cancer Research (2)
  3. JNCI: Journal of the National Cancer Institute (2)
  4. Journal of Clinical Oncology (2)
  5. American Journal of Clinical Dermatology (1)
  6. Blood Reviews (1)

More Publications

Publishers
  1. Wiley Blackwell (3)
  2. American Association for Cancer Research (2)
  3. American Society of Clinical Oncology (2)
  4. Oxford University Press (2)
  5. Adis International Ltd (1)
  6. Churchill Livingstone (1)

More Publishers

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The development of biologic end points in patients treated with differentiation agents: An experience of retinoids in prostate cancer
    Journal Article

    Kelly, W. K.; Osman, I.; Reuter, V. E.; Curley, T.; Heston, W. D. W.; Nanus, D. M.; Scher, H. I.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Phase II clinical trial of 13-cis-retinoic acid and interferon-α-2a in patients with advanced esophageal carcinoma
    Journal Article

    Enzinger, P. C.; Ilson, D. H.; Saltz, L. B.; Martin, L. K.; Kelsen, D. P.
    Cancer (1999)

    Fulltext@MSK | Save
  • Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
    Journal Article

    Miller, V. A.; Benedetti, F. M.; Rigas, J. R.; Verret, A. L.; Pfister, D. G.; Straus, D.; Kris, M. G.; Crisp, M.; Heyman, R.; Loewen, G. R.; more...
    Journal of Clinical Oncology (1997)

    Fulltext@MSK | Save
  • Toxicity of isotretinoin in a chemoprevention trial to prevent second primary tumours following head and neck cancer
    Journal Article

    Benner, S. E.; Pajak, T. F.; Stetz, J.; Lippman, S. M.; Hong, W. K.; Schantz, S. P.; Gallagher, M. J.; Shenouda, G.
    JNCI: Journal of the National Cancer Institute (1994)

    Fulltext@MSK | Save
  • Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole
    Journal Article

    Rigas, J. R.; Francis, P. A.; Muindi, J. R. F.; Kris, M. G.; Huselton, C.; Degrazia, F.; Orazem, J. P.; Young, C. W.; Warrell, R. P. Jr
    JNCI: Journal of the National Cancer Institute (1993)

    Fulltext@MSK | Save
  • 13-cis-retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia
    Journal Article

    Arlin, Z. A.; Mertelsmann, R.; Berman, E.; Gee, T.; Kurland, E.; Chaganti, R. S. K.; Jhanwar, S. C.; Moore, M. A. S.; Clarkson, B. D.
    Journal of Clinical Oncology (1985)

    Fulltext@MSK | Save